Dr. Hans Riegel Holding
Joseph-Beuys-Allee 14, Bonn, Nordrhein-Westfalen, 53113, Germany
Overview
The Hans Riegel Foundation is a NPo that supports young people in shaping their future.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- one • fıve
Led · Series A · Jan 2026
Headquartered in Hamburg, one.five offers an AI-driven solution that converts technical performance data, regulatory constraints, and consumer preferences into precise requirement profiles for new packaging materials. This data-centric approach is designed to cut R&D waste and shorten time-to-market for sustainable paper-based packaging. The company was founded by Martin Weber, former CFO of vertical-farming unicorn Infarm, and Claire Hae-Min Gusko. Early commercial traction includes collaborations with paper manufacturers Starkraft (a Zellstoff Pöls AG unit) and Grünperga Papier, while it is also cultivating partnerships with converters and global FMCG brands. The recently secured Series A funding will finance further platform development and international operational expansion. Although no revenue or user numbers were disclosed, the company positions itself as a critical technology layer within the packaging supply chain, aiming to deliver market-ready, regulation-compliant materials more efficiently.
- Infinite Roots
Led · Series B · Jan 2024
Infinite Roots (formerly Mushlabs) is a German biotech company developing products from fungal mycelium for applications ranging from food to materials. The company closed a $58M Series B to accelerate commercial growth and expand production capacity. IR plans to use the capital to invest in launch activities and scale using an asset-light production approach. That approach includes partnering with existing industrial facilities and refurbishing parts of a large German brewery to use brewery capacity and waste as a production hub. The firm faces well-funded competitors in the mycelium space, including Meati, Nature’s Fynd, Myco Technology, Enough, and Quorn. Founder and CEO Dr. Mazen Rizk said the funding reflects the company’s ability to scale its technology toward industrial production. Mushlabs develops liquid-fermentation processes to grow edible mushroom mycelium for use in alternative-protein and meat-replacement products. Its mycelia are fed on agrifood sidestreams, producing biomass in four to five days and enabling a highly circular, lower-water, lower-footprint process. The startup highlights nutritional benefits (protein, micronutrients, fiber with prebiotic properties) and a cleaner label versus some competitors, using recognizable edible mushroom varieties. Mushlabs sees potential for decentralized, mobile production that can operate year-round and support localized food supply during crises. Since launching in mid-2018 the company has built an 11-person team with experience at Unilever and Marley Spoon. It plans to use new capital to scale to industrial production, build a sales function, and is considering consumer-facing offerings.
Team
No current team members are available.